FDA Says Mounjaro Injections Available In 2.5mg, 5mg, And 10mg; Zepbound Injections Available In 2.5mg, 5mg, And 12.5mg
Portfolio Pulse from Benzinga Newsdesk
The FDA has announced the availability of Mounjaro injections in 2.5mg, 5mg, and 10mg doses, and Zepbound injections in 2.5mg, 5mg, and 12.5mg doses.
August 02, 2024 | 6:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly (LLY) has received FDA approval for the availability of Mounjaro injections in 2.5mg, 5mg, and 10mg doses, and Zepbound injections in 2.5mg, 5mg, and 12.5mg doses.
The FDA approval for the availability of Mounjaro and Zepbound injections in various doses is a positive development for Eli Lilly. This approval can potentially lead to increased sales and market share for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100